-
Founded in:
1993-10-23 -
Country:
China -
Address:
No. 905, Xinjinqiao Road, China (Shanghai) Pilot Free Trade Zone -
Tax NO.:
91310000133742534B -
Registered Funds:
1,191,611,312 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chrysophanic acid |
This product cannot be taken at the same time as enteric-coated tablets. If used at the same time with other drugs, drug interactions may occur. Please consult your doctor or pharmacist for details.
More
This product cannot be taken at the same time as enteric-coated tablets. If used at the same time with other drugs, drug interactions may occur. Please consult your doctor or pharmacist for details. |
0.15g | 481-74-3 | 0 |
| Sodium bicarbonate |
This product cannot be taken at the same time as enteric-coated tablets. If used at the same time with other drugs, drug interactions may occur. Please consult your doctor or pharmacist for details.
More
This product cannot be taken at the same time as enteric-coated tablets. If used at the same time with other drugs, drug interactions may occur. Please consult your doctor or pharmacist for details. |
0.15g | 144-55-8 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ephedrine hydrochloride |
It can directly stimulate adrenaline receptors, and can also indirectly stimulate adrenaline receptors by prompting adrenaline nerve endings to release norepinephrine. It has a stimulating effect on both alpha and beta receptors. It can dilate bronchi and constrict local blood vessels, and its action time is longer; it strengthens myocardial contractility, increases cardiac output, and makes venous return to the heart sufficient; it has a stronger central nervous system stimulating effect than adrenaline.
More
It can directly stimulate adrenaline receptors, and can also indirectly stimulate adrenaline receptors by prompting adrenaline nerve endings to release norepinephrine. It has a stimulating effect on both alpha and beta receptors. It can dilate bronchi and constrict local blood vessels, and its action time is longer; it strengthens myocardial contractility, increases cardiac output, and makes venous return to the heart sufficient; it has a stronger central nervous system stimulating effect than adrenaline. |
25mg | 0 | |
| Diphenhydramine Hydrochloride |
It has ① antihistamine effect, which can compete with histamine released from tissues for H1 receptors on effector cells, thereby stopping allergic reactions; ② at the same time, it inhibits central nervous system activity and causes sedative and hypnotic effects; ③ it enhances the effect of antitussive drugs.
More
It has ① antihistamine effect, which can compete with histamine released from tissues for H1 receptors on effector cells, thereby stopping allergic reactions; ② at the same time, it inhibits central nervous system activity and causes sedative and hypnotic effects; ③ it enhances the effect of antitussive drugs. |
25mg | 147-24-0 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Benproperine phosphate |
Non-narcotic antitussive drugs that block afferent sensory nerve impulses to lung and pleural receptors, inhibit the antitussive center, and have a papaverine-like smooth muscle spasmolytic effect
More
Non-narcotic antitussive drugs that block afferent sensory nerve impulses to lung and pleural receptors, inhibit the antitussive center, and have a papaverine-like smooth muscle spasmolytic effect |
26.4mg | 19428-14-9 | 19 |
| BENPROPERINE |
Non-narcotic antitussive drugs that block afferent sensory nerve impulses to lung and pleural receptors, inhibit the antitussive center, and have a papaverine-like smooth muscle spasmolytic effect
More
Non-narcotic antitussive drugs that block afferent sensory nerve impulses to lung and pleural receptors, inhibit the antitussive center, and have a papaverine-like smooth muscle spasmolytic effect |
20mg | 2156-27-6 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Benproperine phosphate |
Non-narcotic antitussive drugs mainly block the afferent sensory nerve impulses of the lung and pleural receptors, and also directly inhibit the antitussive center. It also has a papaverine-like smooth muscle spasmolytic effect
More
Non-narcotic antitussive drugs mainly block the afferent sensory nerve impulses of the lung and pleural receptors, and also directly inhibit the antitussive center. It also has a papaverine-like smooth muscle spasmolytic effect |
26.4mg | 19428-14-9 | 19 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Beclomethasone dipropionate |
A synthetic, potent topical adrenocortical hormone. It has anti-inflammatory, anti-allergic, antipruritic and exudation-reducing effects, can inhibit bronchial exudates, eliminate bronchial mucosal swelling, and relieve bronchospasm; it can reduce and prevent tissue responses to inflammation, and can eliminate fever, redness and swelling caused by local non-infectious inflammation, thereby reducing the manifestations of inflammation; it has an immunosuppressive effect, preventing or inhibiting cell-mediated immune responses, delayed allergic reactions, and reducing the expansion of primary immune responses; topical application has very weak effects on sodium retention and hepatic gluconeogenesis, has no male, female and protein anabolic hormone-like effects, and has no significant effect on body temperature and urine. Inhalation administration is more effective than oral administration for bronchial wheezing.
More
A synthetic, potent topical adrenocortical hormone. It has anti-inflammatory, anti-allergic, antipruritic and exudation-reducing effects, can inhibit bronchial exudates, eliminate bronchial mucosal swelling, and relieve bronchospasm; it can reduce and prevent tissue responses to inflammation, and can eliminate fever, redness and swelling caused by local non-infectious inflammation, thereby reducing the manifestations of inflammation; it has an immunosuppressive effect, preventing or inhibiting cell-mediated immune responses, delayed allergic reactions, and reducing the expansion of primary immune responses; topical application has very weak effects on sodium retention and hepatic gluconeogenesis, has no male, female and protein anabolic hormone-like effects, and has no significant effect on body temperature and urine. Inhalation administration is more effective than oral administration for bronchial wheezing. |
5534-09-8 | 26 |